Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04214860 |
| Title | APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Aprea Therapeutics AB |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale Cancer Center | New Haven | Connecticut | 06511 | United States | Details | |
| H. Lee Moffitt CC | Tampa | Florida | 33612 | United States | Details | |
| Northwestern Medicine | Chicago | Illinois | 60611 | United States | Details | |
| University of Chicago Medicine | Chicago | Illinois | 60637 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| Weill Cornell Cancer Center | New York | New York | 10021 | United States | Details | |
| Memorial Sloan Kettering CC | New York | New York | 10065 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |